title: Effect of esomeprazole on gastroduodenal erosions in patients at increased gastrointestinal risk treated with low-dose acetylsalicylic acid: a post-hoc analysis of the OBERON trial.
authors.affiliation: Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, 3912 Taubman Center, SPC 5362, Ann Arbor, MI 48109, USA. Electronic address: jscheima@med.umich.edu.
authors.forename: James M
authors.initials: JM
authors.lastname: Scheiman
authors.affiliation: Servicio de Aparato Digestivo, University Clinic Hospital, University of Zaragoza, CIBERehd, IIS Aragón, Calle de San Juan Bosco 15, 5009 Zaragoza, Spain. Electronic address: angel.lanas@gmail.com.
authors.forename: Angel
authors.initials: A
authors.lastname: Lanas
authors.affiliation: Division of Gastroenterology, Department of Medicine, 130 University Campus, University of Alberta, Edmonton, Alberta T6G 2X8, Canada. Electronic address: vanzanten@ualberta.ca.
authors.forename: Sander
authors.initials: S
authors.lastname: Veldhuyzen van Zanten
authors.affiliation: AstraZeneca LP, 1800 Concord Pike, P.O. Box 15437, Wilmington, DE 19850-5437, USA. Electronic address: irina.baldycheva@astrazeneca.com.
authors.forename: Irina
authors.initials: I
authors.lastname: Baldycheva
authors.affiliation: AstraZeneca R&D, Pepparedsleden 1, Mölndal SE-431 83, Sweden. Electronic address: laersve@gmail.com.
authors.forename: Lars-Erik
authors.initials: LE
authors.lastname: Svedberg
authors.affiliation: AstraZeneca R&D, Pepparedsleden 1, Mölndal SE-431 83, Sweden. Electronic address: peter.nagy@astrazeneca.com.
authors.forename: Péter
authors.initials: P
authors.lastname: Nagy
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D064098:Esomeprazole / Q000008:administration & dosage*; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D014943:Global Health; D006801:Humans; D015994:Incidence; D010437:Peptic Ulcer / Q000188:drug therapy*; D054328:Proton Pump Inhibitors / Q000008:administration & dosage; D018570:Risk Assessment
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D054328:Proton Pump Inhibitors; D064098:Esomeprazole; D001241:Aspirin
keywords: Acetylsalicylic acid; Esomeprazole; Gastroduodenal erosion; Low-dose